Skip to Content

Altabax Approval History

  • FDA approved: Yes (First approved April 12th, 2007)
  • Brand name: Altabax
  • Generic name: retapamulin
  • Dosage form: Ointment
  • Company: GlaxoSmithKline
  • Treatment for: Impetigo

Altabax (retapamulin) is a topical antibiotic indicated for the treatment of impetigo in adults and children aged 9 months and older.

Development History and FDA Approval Process for Altabax

Apr 13, 2007Approval GSK Announces FDA Approval of Altabax (Retapamulin Ointment), 1%
Dec 22, 2006GSK Receives Approvable Letter for Topical Antibiotic, Altabax (retapamulin ointment), 1%
Feb 14, 2006GlaxoSmithKline's Topical Antibacterial Retapamulin Accepted for Review by The U.S. Food and Drug Administration

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.